Air Products Walked Away From Its Hydrogen Mega-Bet. The Growth Engine Is the Real Open Question

While Air Products readies a booth for a trade show courting glassmakers in Toledo — the unglamorous, bread-and-butter pitch that it can keep industrial furnaces, chip fabs, and hospital oxygen lines running — the company's most consequential recent act was the opposite of steady. On June 30 it announced it would not proceed with the Louisiana Clean Energy Complex, its zero-carbon liquid hydrogen plant in Arizona, and the rest of a clean-energy distribution build-out, and it recorded a $2.9 billion pretax charge to make the exit official.

If you only read the headline numbers, this looks like a catastrophe. The charge — $2.2 billion after tax, or $9.92 a share — dragged the fiscal third quarter into a GAAP loss of $6.47 a share on a $2.1 billion operating loss. The screen makes it look worse: Air Products' trailing P/E is negative and its EV-to-EBITDA sits near 86 times, artifacts of a one-time charge chewing through a twelve-month window rather than a verdict on the business.

Strip the charge out, though, and the quarter was a solid one underneath — a beat, not a bust. That distinction is the story.

The charge is the cleanup, not the damage

Adjusted EPS came in at $3.47, up 12% year over year and above the top of guidance. Adjusted operating income rose 9%, and adjusted operating margin expanded 110 basis points to 25.6%. Management raised full-year fiscal 2026 adjusted EPS guidance to $13.39–$13.49 — roughly 11% to 12% growth — and, just as telling, cut planned capital spending to about $3.5 billion now that a greenfield agenda has been culled.

This is a pivot you can date. Eduardo Menezes, a former Linde executive who ran industrial gas operations across the globe, took over as chief executive in February 2025 from Seifi Ghasemi, the architect of Air Products' clean-hydrogen, first-mover posture. Menezes' moves since read as the opposite philosophy: cost efficiency and capital discipline ahead of being first. The June charges are the clean break — the formal admission that betting billions on hydrogen demand before that demand existed, on facilities that would take years to build, had failed the test of manufacturing and market execution.

What is actually accelerating underneath is not the clean-energy story. The beat came from the weather-the-cycle core: on-site industrial gas volumes, new plants ramping in Asia and the Americas, and higher production from U.S. refinery assets. Helium was a drag of roughly two points on weak prices and lower space volumes. And management was candid that Europe and Asia remain sluggish, with overcapacity in China. This quarter was a cyclical industrial-gas operator executing well, not a green-transition growth story.

The one bet left standing

The retreat is not total. Air Products kept its Saudi Arabian NEOM plant — the world's largest green-hydrogen-made-into-ammonia facility — a roughly $8.4 billion project about 80% complete, headed for commissioning around the third quarter of 2026 on the strength of a 30-year offtake. It just signed a marketing and distribution agreement with Yara for the renewable ammonia, which removes the volume risk that sank its U.S. ambitions. But Menezes has said he expects no material financial impact from NEOM in fiscal 2027, and Air Products keeps the price risk on the ammonia even as it shifts the volume risk elsewhere. NEOM is now a position with its downside hedged, not a near-term earnings engine.

What the market is paying for

The market has largely bought the new story. The stock is up roughly 19% year to date and trades near its 52-week high even as the GAAP loss hits the screen — a correct first read that investors are rewarding the removal of capital risk rather than punishing an accounting loss. But it is also the point where I pause. Walking away removed two large pieces of the forward earnings growth those billions of capital were meant to buy. Greenfield projects, for all their risk, were the reason Air Products could point to earnings growth above its cyclical base. Take them off the table and you are left with a cleaner company on an easier-to-read multiple — and a smaller growth engine to make that multiple worth paying.

So I'd frame the trade on the numbers, not the narrative. If the refocused core can keep compounding adjusted EPS in the low double digits now that capital spending is coming down — which the raised guidance and the quarter itself support — the de-risked story can still earn its price. If the industrial cycle softens, with Europe and China already looking weak, then growth rests entirely on a cyclical business, and the market has paid up for a retreat that also took away the upside. The single fact that separates the two is whether adjusted EPS keeps growing at a double-digit clip with the mega-projects gone — and that is a question the next couple of quarters, not the write-down, will settle.